Literature DB >> 33463377

An improved staining method of cell cycle analysis with Sybr Green I for fungi: Cryptococcus neoformans and Saccharomyces cerevisiae.

Zhongkai Gu1.   

Abstract

Cryptococcus neoformans is a pathogenic fungus which causes millions of deaths and infections, especially threatening immunocompromised individuals. During the development of new drugs, the ubiquitination has been found to play an important role in the regulation of the virulence and cell cycle of this fungus. Based on this mechanism, ubiquitination-related mutant strains exhibiting cell cycle arrest have been established for drug development for the fungus. However, flow cytometry detection of the cell cycle in fungi is generally difficult because the thick cell wall and capsule of fungi generally contribute to a nonspecific signal of cytometry. In this study, an improved method, derived from Saccharomyces cerevisiae assays, is developed to specifically stain C. neoformans, in whose cell cycle the G1 and G2 peaks are separated enough to be allowed for cell cycle analysis. As a result, the improved method facilitates the detection of the alterations in the cell cycle of C. neoformans with a mutation that results in cell cycle arrest, which distinctly delays the cell division of C. neoformans. Thus, the improved method reported here provides detailed technical information regarding assays on C. neoformans and, more importantly, offers a solution for assessing the cell cycle in other fungi in the future. Abbreviation: PI: propidium iodide.

Entities:  

Keywords:  Cryptococcus neoformans ; Saccharomyces cerevisiae ; Cytometry; PI; Sybr Green; cell cycle; staining; yeast

Mesh:

Substances:

Year:  2021        PMID: 33463377      PMCID: PMC7889188          DOI: 10.1080/15384101.2020.1870334

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  24 in total

1.  Flow cytometric analysis of DNA content in budding yeast.

Authors:  S B Haase; D J Lew
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

Review 2.  Pulmonary Cryptococcosis.

Authors:  C C Chang; T C Sorrell; S C-A Chen
Journal:  Semin Respir Crit Care Med       Date:  2015-09-23       Impact factor: 3.119

Review 3.  Genetics of Cryptococcus neoformans.

Authors:  Christina M Hull; Joseph Heitman
Journal:  Annu Rev Genet       Date:  2002-06-11       Impact factor: 16.830

4.  Improved flow cytometric analysis of the budding yeast cell cycle.

Authors:  Steven B Haase; Steven I Reed
Journal:  Cell Cycle       Date:  2002 Mar-Apr       Impact factor: 4.534

Review 5.  Cryptococcus neoformans: the yeast that likes it hot.

Authors:  John R Perfect
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

6.  Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant.

Authors:  D Finley; S Sadis; B P Monia; P Boucher; D J Ecker; S T Crooke; V Chau
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.

Authors:  T R Kozel; E C Gotschlich
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

8.  Pleiotropic effects of deubiquitinating enzyme Ubp5 on growth and pathogenesis of Cryptococcus neoformans.

Authors:  Wei Fang; Michael S Price; Dena L Toffaletti; Jennifer Tenor; Marisol Betancourt-Quiroz; Jennifer L Price; Wei-hua Pan; Wan-qing Liao; John R Perfect
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

9.  Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.

Authors:  Tomomi Saijo; Jianghan Chen; Sharon C-A Chen; Lindsey B Rosen; Jin Yi; Tania C Sorrell; John E Bennett; Steven M Holland; Sarah K Browne; Kyung J Kwon-Chung
Journal:  MBio       Date:  2014-03-18       Impact factor: 7.867

Review 10.  Cryptococcal meningitis: epidemiology and therapeutic options.

Authors:  Derek J Sloan; Victoria Parris
Journal:  Clin Epidemiol       Date:  2014-05-13       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.